Chemistry:LY-2109761
From HandWiki
Short description: Synthetic compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C26H27N5O2 |
Molar mass | 441.535 g·mol−1 |
3D model (JSmol) | |
| |
|
LY-2109761 is a synthetic compound which acts as a potent and selective inhibitor for the growth factor receptor TGF beta receptor 1. It is used for research into conditions such as pulmonary fibrosis and cancer.[1][2]
See also
- Galunisertib
- GW788388
References
- ↑ "LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis". Molecular Cancer Therapeutics 7 (4): 829–840. April 2008. doi:10.1158/1535-7163.MCT-07-0337. PMID 18413796.
- ↑ "TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells". Cellular Physiology and Biochemistry 50 (2): 757–767. 2018. doi:10.1159/000494241. PMID 30308508.
Original source: https://en.wikipedia.org/wiki/LY-2109761.
Read more |